Your shopping cart is currently empty

PSB-1901 is a highly potent and selective A2B adenosine receptor antagonist exhibiting picomolar affinity for human A2BAR with exceptional subtype selectivity exceeding 10,000-fold over other adenosine receptors, while maintaining comparable potency in mouse A2BAR, making PSB-1901 a powerful pharmacological probe for preclinical investigations of adenosine-mediated signaling pathways.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $373 | - | In Stock | |
| 5 mg | $893 | - | In Stock | |
| 10 mg | $1,220 | - | In Stock | |
| 25 mg | $1,820 | - | In Stock | |
| 50 mg | $2,380 | - | In Stock |
| Description | PSB-1901 is a highly potent and selective A2B adenosine receptor antagonist exhibiting picomolar affinity for human A2BAR with exceptional subtype selectivity exceeding 10,000-fold over other adenosine receptors, while maintaining comparable potency in mouse A2BAR, making PSB-1901 a powerful pharmacological probe for preclinical investigations of adenosine-mediated signaling pathways. |
| Targets&IC50 | P2Y6 Receptor:< 100 nM (EC50) |
| In vitro | In pharmacological assays, PSB-1901 acted as a full agonist of the human P2Y6 receptor with an EC50 in the nM range, triggering Gq-protein coupled signaling and intracellular calcium mobilization [1]. |
| In vivo | In physiological models, PSB-1901 is used to investigate P2Y6-mediated biological responses. In the immune system, activation of P2Y6 receptors on microglia drives phagocytosis, a process for clearing cellular debris and pathogens. In the cardiovascular system, PSB-1901 is associated with vasoconstriction. Its metabolic stability allows for the study of prolonged physiological effects without confounding factors from rapid ligand degradation [1]. |
| Synonyms | PSB-1901 free base, PSB1901, PSB 1901 |
| Molecular Weight | 573.46 |
| Formula | C24H25BrN6O4S |
| Cas No. | 2332835-02-4 |
| Smiles | O=C1NC=2N=C(NC2C(=O)N1CCC)C=3C=CC(=CC3)S(=O)(=O)N4CCN(C5=CC=C(Br)C=C5)CC4 |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (139.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.